Anthony Holler - CRH Medical Insider

CRH Medical Corporation -- Canada Stock  

CAD 3.48  0.01  0.29%

Independent Chairman of the Board

Dr. Anthony F. Holler, M.D., is Independent Chairman of the Board of CRH Medical Corporationrationration, since December 21, 2005. Dr. Holler was appointed as a director of the Company on December 21, 2005. Dr. Holler is one of the founders of ID Biomedical Corporationrationration and held a number of executive positions with ID Biomedical including Chief Executive Officer and Director
Age: 62  Chairman Since 2005  Ph.D    
Holler resigned from ID Biomedical upon the completion of ID Biomedical acquisition by GlaxoSmithKline. Prior to founding ID Biomedical, Dr. Holler served as an emergency physician at University Hospital at the University of British Columbia.

Management Efficiency

The company has return on total asset (ROA) of 7.35 % which means that it generated profit of $7.35 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on equity (ROE) of 12.64 % meaning that it generated $12.64 on every $100 dollars invested by stockholders.
The company has accumulated 64.18 M in total debt with debt to equity ratio (D/E) of 51.8 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. CRH Medical Corporation has Current Ratio of 2.36 suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due.

Similar Executives

Found 2 records


Charles OSullivanHemisphere Energy Corporation
Nolan BladesFreehold Royalties Ltd

Entity Summary

CRH Medical Corporationration offer solutions and services to physicians for the treatment of gastrointestinal diseases in the United States. CRH Medical Corporation (CRH) is traded on Toronto Stock Exchange in Canada. It is located in Vancouver, BC VC E and employs 13 people.
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add CRH Medical Corporation to your portfolio

Top Management

CRH Medical Leadership Team
Adam Peeler, Executive
Bergein Overholt, Director
Edward Wright, CEO
David Johnson, Director
Todd Patrick, Director
Richard Bear, CFO, CPA
Ian Webb, Director
Jay Kreger, President
Anthony Holler, Chairman, Ph.D

Stock Performance

CRH Medical Performance Indicators